Intra-arterial chemoradiation for T3-4 oral cavity cancer: Treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma

World Journal of Surgical Oncology

Volumn 6, Issue , 2008, Pages

  Doweck, Ilana ^a   Thomas, K Thomas ^b   Samant, Sandeep ^c   Vieira, Francisco ^c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADULT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOTOXICITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HYPOPHARYNX CARCINOMA; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MUCOSA INFLAMMATION; NEUROTOXICITY; OROPHARYNX CARCINOMA; OTOTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; SURVIVAL RATE; ADJUVANT THERAPY; AGED; COHORT ANALYSIS; HYPOPHARYNX TUMOR; IMMUNOHISTOCHEMISTRY; INTRAARTERIAL DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; MOUTH TUMOR; MULTIMODALITY CANCER THERAPY; OROPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 40149083424     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-6-2     Document Type: Article

References (21)

1. Bourhis J Amand C Pignon JP: MACH-NC Collaborative Group Update of MACH-NC (meta-analysis of chemotherapy in head & neck cancer) database focused on concomitant chemotherapy [abstract 5505]. Proc ASCO 2004, 22:14S-489. http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/ Abstracts?&vmview=abst_detail_view&confID=26&abstractID=3198
2. Adelstein DJ Li Y Adams GL Wagner H Jr Kish JA Ensley JF Schuller DE Forastiere AA: An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003, 21:92-98. 10.1200/JCO.2003.01.008 12506176
3. Forastiere AA Goepfert H Maor M Pajak TF Weber R Morrison W Glisson B Trotti A Ridge JA Chao C Peters G Lee DJ Leaf A Ensley J Cooper J: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098. 2003 Nov 27 10.1056/NEJMoa031317 14645636
4. Robbins KT Kumar P Wong FSH Hartsell WF Flick P Palmer R Weir AB 3rd Neill HB Murry T Ferguson R Hanchett C Vieira F Bush A Howell SB: Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients. Head Neck 2000, 22:687-693. 11002324 11002324 10.1002/ 1097-0347(200010)22:7<687::AID-HED8>3.0.CO;2-W
5. Doweck I Robbins KT Vieira F: Analysis of risk factors predictive of distant failure after targeted chemoradiation for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2001, 127:1315-1318. 11701066
6. Robbins KT Doweck I Samant S Vieira F Kumar P: Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT). Laryngoscope 2004, 114:411-417. 10.1097/ 00005537-200403000-00004 15091211
7. Fein DA Mendenhall WM Parsons JT McCarty PJ Stringer SP Million RR Cassisi NJ: Carcinoma ofAthe oral tongue: a comparison of results and complications of treatment with radiotherapy and/or surgery. Head Neck 1994, 16:358-365. 10.1002/hed.2880160410 8056581
8. Palme CE Gullane PJ Gilbert RW: Current treatment options in squamous cell carcinoma of the oral cavity. Surg Oncol Clin N Am 2004, 13:47-70. 10.1016/S1055-3207(03)00123-6 15062361
9. Koch WM Lee DJ Eisele DW Miller D Poole M Cummings CW Forastiere A: Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1995, 121:974-980. 7646865
10. Taylor SG 4th Murthy AK Griem KL Recine DC Kiel K Blendowski C Hurst PB Showel JT Hutchinson JC Jr Campanella RS Chen S Caldarelli DD: Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer: 8-year analysis of results. Head Neck 1997, 19:684-691. 10.1002/(SICI)1097-0347(199712)19:8<684::AID-HED68>3.0.CO;2-1 9406747
11. Chougule P Wanebo H Akerley W McRae R Nigri P Leone L Safran H Ready N Koness RJ Radie-Keane K Cole B: Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: A phase II study - preliminary results. Semin Oncol 1997, 24 (6 Suppl 19):S19-57. S19-61 9427268
12. Lavertu P Adelstein DJ Saxton JP Secic M Eliachar I Strome M Larto MA Wood BG: Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: An 8-year single-institution experience. Arch Otolaryngol Head Neck Surg 1999, 125:142-148. 10037279
13. Pradier O Eberlein K Weiss E Jackel MC Hess CF: Radiotherapy combined with simultaneous chemotherapy with mitomycin-C and 5-fluorouracil for inoperable head and neck cancer. Br J Radiol 2001, 74:368-374. 11387156
14. Fornari G Artusio E Mairone L Airoldi M Bongioannini G Amasio E Rosmino C Gabriele P: Paclitaxel and carboplatin in neo-adjuvant and concomitant chemoradiotherapy in locally advanced head and neck squamous cell carcinoma. Tumori 2002, 88:489-494. 12597144
15. Airoldi M Cattel L Cortesina G Giordano C Pedani F Recalenda V Danova M Gabriele AM Tagini V Porta C Bumma C: Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: Pharmacokinetic and clinical data of a phase I-II study. Am J Clin Oncol 2004, 27:155-163. 10.1097/01.coc.0000054533.02062.09 15057155
16. Greene FL Page DL Fleming ID Fritz A Balch CM Haller DG Morrow M (Eds.) AJCC Cancer Staging Manual Springer-Verlag, New-York 6 2002.
17. Mohr C Bohndorf W Carstens J Härle F Hausamen JE Hirche H Kimmig H Kutzner J Mühling J Reuther J: Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone: A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up). Int J Oral Maxillofac Surg 1994, 23:140-148. 10.1016/S0901-5027(05)80288-7 7930766
18. Eckardt A Rades D Rudat V Hofele C Dammer R Dietl B Wildfang I Karstens JH: Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome. Mund Kiefer Gesichtschir 2002, 6:117-121. 10.1007/s10006-002-0370-y 12017874
19. Balm AJ Rasch CR Schornagel JH Hilgers FJ Keus RB Schultze-Kool L Ackerstaff AH Busschers W Tan IB: High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 2004, 26:485-493. 10.1002/ hed.20006 15162349
20. Newman LA Vieira F Schwiezer V Samant S Murry T Woodson G Kumar P Robbins KT: Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1998, 124:589-592. 9604988
21. Newman LA Robbins KT Logemann JA Rademaker AW Lazarus CL Hamner A Tusant S Huang CF: Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck 2002, 24:68-77. 10.1002/hed.10000 11774405